We discussed the impact of an SNP in both the promoter and coding regions of PNPLA3, exploring how these polymorphisms influence the pathogenesis of NAFLD and NASH. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.